Avita Medical share price spikes 10% as sales jump in Q2

MotleyFool08-09

The Avita Medical Ltd (ASX: AVH) share price is rallying hard on Friday, up 10% to trade at $14.82 at the time of writing. This follows the release of the company's financial results for the quarter ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2458215302?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-09 10:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2458215302","market":"hk","top_or_hot":-1,"title":"Avita Medical share price spikes 10% as sales jump in Q2","media":"MotleyFool","content":"<div>\n<p>The Avita Medical Ltd (ASX: AVH) share price is rallying hard on Friday, up 10% to trade at $14.82 at the time of writing. This follows the release of the company's financial results for the quarter ...</p>\n\n<a href=\"https://www.fool.com.au/2024/08/09/avita-medical-share-price-spikes-10-as-sales-jump-in-q2/\">Source Link</a>\n\n</div>\n","source":"motleyfoolau_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Avita Medical share price spikes 10% as sales jump in Q2</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAvita Medical share price spikes 10% as sales jump in Q2\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-09 10:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com.au/2024/08/09/avita-medical-share-price-spikes-10-as-sales-jump-in-q2/><strong>MotleyFool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Avita Medical Ltd (ASX: AVH) share price is rallying hard on Friday, up 10% to trade at $14.82 at the time of writing. This follows the release of the company's financial results for the quarter ...</p>\n\n<a href=\"https://www.fool.com.au/2024/08/09/avita-medical-share-price-spikes-10-as-sales-jump-in-q2/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AVH.AU","symbol_name":"Avita Therapeutics","start_time":0,"source_url":"https://www.fool.com.au/2024/08/09/avita-medical-share-price-spikes-10-as-sales-jump-in-q2/","article_id":"2458215302","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2458215302","pubTimestamp":1723168969,"sourceInfo":{"source_id":"motleyfoolau_stock","name":"MotleyFool"},"weMediaInfo":null,"summary":"The Avita share price had a mixed performance on the chart last quarter, but the company financials were sound.  Sales were almost 30% higher year over year on a gross profit margin of 86%. Growth in existing customer accounts and \"new accounts for full-thickness skin defect\" underscored this performance. Operating expenses were around $7 million higher to $28 million, as the business spent more towards marketing and employee-related costs.  Avita also achieved several milestones related to its RECELL GO segment. This system is used to treat wounds, particularly burn wounds and full-thickness tears. The milestones include the approval of the RECELL GO system by the US Food and Drug Administration  and the submission of the RECELL GO mini for use on smaller wounds. It also entered into an exclusive development and distribution agreement with Regenity Biosciences.  This will allow the company to commercialise a unique collagen-based dermal matrix following approvals in the USA. What did ","collect":0,"end_time":0,"defaultTopTitle":"fool.com.au","property":[],"viewcount":null,"language":"en","relate_stocks":{"AVH.AU":"Avita Therapeutics","XJO.AU":"标普/澳交所 200指数","BK7067":"生物科技","BK7508":"医药生物股"},"translate_title":"第二季度销售额猛增，阿维塔医疗股价飙升10%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AVH.AU":1,"XJO.AU":1},"content_text":"The Avita Medical Ltd (ASX: AVH) share price is rallying hard on Friday, up 10% to trade at $14.82 at the time of writing. This follows the release of the company's financial results for the quarter ending 30 June 2024.  For context, the S&P/ASX 200 Index (ASX: XJO) is up less than 1% at the time of writing.  Let's see what the company posted. Avita Medical share price jumps on solid Q2 FY24 results Key highlights from the quarter include the following:  Commercial revenue came to $15.1 million, up 29% from the same period in 2023  Gross profit margin was 86.2%, a 500 basis point increase  It achieved FDA approval of RECELL GO for premarket approval (PMA)  The RECELL GO mini submission was submitted for FDA approval on 28 June 2024   What else happened in Q2 FY24? The Avita share price had a mixed performance on the chart last quarter, but the company financials were sound.  Sales were almost 30% higher year over year on a gross profit margin of 86%. Growth in existing customer accounts and \"new accounts for full-thickness skin defect\" underscored this performance. Operating expenses were around $7 million higher to $28 million, as the business spent more towards marketing and employee-related costs.  Avita also achieved several milestones related to its RECELL GO segment. This system is used to treat wounds, particularly burn wounds and full-thickness tears. The milestones include the approval of the RECELL GO system by the US Food and Drug Administration (FDA) and the submission of the RECELL GO mini for use on smaller wounds. It also entered into an exclusive development and distribution agreement with Regenity Biosciences.  This will allow the company to commercialise a unique collagen-based dermal matrix following approvals in the USA. What did management say? CEO Jim Corbett highlighted the company's achievements and future plans, which may be useful for the Avita share price:  Our second-quarter commercial revenue reached a record $15.1 million, reflecting the effectiveness of our enhanced focus on commercial execution.  The FDA approval of RECELL GO and our recent submission of RECELL GO mini highlight our progress in expanding treatment capabilities for burn and full-thickness skin defects.  Additionally, our agreement with Regenity further enhances our ability to address a full spectrum of clinical needs.  What's next? Looking ahead, the business has set ambitious targets for the remainder of FY24 and beyond, which could impact the Avita share price. It is targeting $70 million in revenues and growth of around 40% year over year. It also expects to reach cash flow breakeven and profitability \"no later than the third quarter of 2025\".  Furthermore, Avita anticipates FDA approval of RECELL GO mini by December 27 2024. Avita Medical share price snapshot The Avita Medical share price is catching a strong bid amid today's 10% spike. It is a welcomed change. Over the past 12 months, Avita shares are down nearly 49%.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2458215302"}